
U.S. Medical Imaging Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The U.S. medical imaging market was valued at USD 15.1 billion in 2024 and is projected to increase from USD 15.8 billion in 2025 to USD 24.9 billion by 2034, registering a CAGR of 5.2%, according to the latest report published by Global Market Insights Inc.

The growth of the U.S. medical imaging market is stimulated by several factors, including rising disease burden, technological advancement of medical imaging systems, and growing healthcare expenditure in U.S. Medical imaging uses various technologies in order to create visual representations of the interior part of the body for medical intervention and clinical analysis. Key players in this market include GE HealthCare Technologies, Siemens Healthineers, Koninklijke Philips, Canon Medical Systems, and Fujifilm Holdings.
The market size increased from USD 13.3 billion in 2021 to USD 14.5 billion in 2023, primarily due to the expanding geriatric population. As individuals age, they become more susceptible to chronic illnesses such as cardiovascular diseases, osteoporosis, and cancer, which require frequent hospitalizations and diagnostic procedures. Medical imaging technologies, including MRI, CT scans, and X-rays, are essential in diagnosing and monitoring these conditions, accelerating the demand for advanced medical imaging solutions.
For instance, according to the data from National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men. Among this population, 25% belonged to racially and ethnically diverse communities, demonstrating broad demographic impact. States such as Maine, Florida, West Virginia, and Vermont reported the highest proportion of elderly residents, indicating regions with significant healthcare demands. The increasing elderly population is stimulating the need for advanced imaging tools, establishing medical imaging as an essential component of modern healthcare. Moreover, the market continues to expand as hospitals and clinics respond to this demand, supported by technological advancements and rising patient volumes requiring imaging-based care.
Additionally, the rising incidence of chronic disease is one of the major factors accelerating the growth of the U.S. medical imaging market. Conditions such as Alzheimer's disease, cancer, and cardiovascular diseases, among others, require continuous monitoring, early diagnosis, and precise treatment planning, all of which depend heavily on advanced imaging technology. For instance, in 2025, nearly 7.2 million U.S. citizens aged 65 and older are living with Alzheimer's disease, according to the Alzheimer's Association. These figures highlight the urgent need for technologically advanced diagnostic imaging tools for early detection of neurological changes, tracking disease progression, and supporting clinical decision-making in managing Alzheimer's and related conditions, thereby fostering market growth in the country.
Medical imaging uses various technologies in order to create visual representations of the interior parts of the body for medical intervention and clinical analysis. These imaging technologies help healthcare professionals monitor and diagnose diseases, assess injuries, and guide treatment plans by providing detailed images of tissues, organs, and bones. Common medical imaging devices include CT scanner, medical X-ray, magnetic resonance imaging (MRI) systems, ultrasound, and other medical imaging devices.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2024 |
| Market Size in 2024 | USD 15.1 Billion |
| Forecast Period 2025 – 2034 CAGR | 5.2% |
| Market Size in 2034 | USD 24.9 Billion |
| Key Market Trends | |
| Drivers | Impact |
| Ongoing technological advancements in medical imaging. | Drive innovation, improving diagnostic accuracy and expanding imaging applications, thereby boosting market growth. |
| Rapidly growing geriatric population base. | Increases demand for imaging services due to age-related health conditions such as, osteoporosis, cancer, and cardiovascular diseases. |
| Increasing burden of chronic diseases in U.S. | Fuels the need for frequent and advanced imaging for diagnosis, monitoring, and treatment planning. |
| Rising healthcare investment in U.S. | Enhance infrastructure and access to cutting-edge imaging technologies, accelerating market expansion. |
| Pitfalls & Challenges | Impact |
| Stringent regulatory concerns | Delay product approvals and adoption of new technologies, increasing compliance costs and hindering market expansion. |
| Opportunities: | Impact |
| Development of portable and point-of-care imaging devices | Facilitates faster diagnostics in emergency and outpatient settings, improving efficiency and patient outcomes. |
| Market Leaders (2024) | |
| Market Leaders |
40.2% Market share |
| Top Players |
Collective market share in 2024 is 96% |
| Competitive Edge |
|
| Future outlook |
|

The market was valued at USD 13.3 billion in 2021. The market size reached USD 14.5 billion in 2023, from USD 14 billion in 2022.
Based on the product, the U.S. medical imaging market is segmented into X-ray devices, MRI, ultrasound, computed tomography, nuclear imaging, and mammography. The X-ray devices segment dominated the market in 2024. This segment was valued at USD 4.6 billion in 2024 and is projected to reach USD 7.4 billion by 2034, growing at a CAGR of 4.9%. In comparison, the MRI segment, valued at USD 2.3 billion in 2024, is expected to grow to USD 4.1 billion by 2034, with a CAGR of 6%.

Based on end use, the U.S. medical imaging market is segmented into hospitals, diagnostic centers, and other end users. The hospitals segment accounted for the highest market share of 52.6% in 2024.
Few of the prominent players operating in the U.S. medical imaging industry include:
Siemens Healthineers AG is a leader in developing and manufacturing a wide array of healthcare products and solutions aimed at enhancing patient outcomes across various medical disciplines. The company delivers innovative technologies across multiple segments, including in-vitro diagnostics for laboratories, hospitals, and point-of-care testing. Operating through regional subsidiaries in Germany, the U.S., Asia, and over 70 other countries, Siemens Healthineers continues to advance healthcare delivery. Its focus remains on transforming patient care through cutting-edge medical technologies and a commitment to improving lives worldwide.
Shimadzu operates in over 100 countries through a network of subsidiaries and offices across the Americas, Europe, Asia, and other regions. The company offers advanced diagnostic imaging solutions designed to enhance clinical precision and improve workflow efficiency, particularly in surgical and interventional procedures.
Hologic medical technology company specializing in diagnostic imaging systems, surgical devices, and molecular diagnostics, with a strong focus on women’s health. Headquartered in Marlborough, Massachusetts, Hologic serves hospitals and clinics across the U.S. through direct operations and strategic partnerships. The company leads in breast health and diagnostics, contributing significantly to the U.S. medical imaging market.
Market, By Product
Market, By End Use
Key players include Canon Medical Systems, Carestream Health, Esaote, Fujifilm Holdings, GE HealthCare Technologies, Hologic, Konica Minolta, Koninklijke Philips, Samsung Medison, and Shimadzu.
Key trends include rising healthcare spending, increased adoption of advanced diagnostic technologies, and the growing prevalence of chronic diseases requiring imaging services.
The hospitals segment accounted for the largest market share of 52.6% in 2024, driven by the high adoption of advanced imaging technologies in hospital settings.
The MRI segment, valued at USD 2.3 billion in 2024, is expected to grow to USD 4.1 billion by 2034, with a CAGR of 6% during the forecast period.
The U.S. medical imaging market was valued at USD 15.1 billion in 2024, with a CAGR of 5.2% projected through 2034. The market is driven by advancements in diagnostic technologies, increased healthcare spending, and improved infrastructure.
The market is expected to reach USD 24.9 billion by 2034, fueled by rising demand for advanced imaging modalities and broader access to imaging services.
The X-ray devices segment was valued at USD 4.6 billion in 2024 and is projected to grow to USD 7.4 billion by 2034, registering a CAGR of 4.9% during the forecast period.


